Mucomyst and Loraz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucomyst (acetylcysteine) and Loraz (lorazepam). Common drug interactions include international normalised ratio increased among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Mucomyst and Loraz. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

On Jul, 15, 2026

49 people who take Mucomyst and Loraz together, and have interactions are studied.

What are the common drug interactions of Mucomyst and Loraz, by gender? *:

female:

International normalised ratio increased
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
Uterine cancer
Colitis (inflammation of colon)
Enterocutaneous fistula
Intestinal obstruction
Intestinal perforation (complete penetration of the wall of the intestine)
Venous thrombosis (blood clot (thrombus) that forms within a vein)
Abdominal discomfort
Abscess limb (limb infection)

male:

Renal failure acute (rapid kidney dysfunction)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Nausea (feeling of having an urge to vomit)
Pleural effusion (water on the lungs)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Staphylococcal infection (an infection with staphylococcus bacteria)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Abdominal wound dehiscence (abdominal wound ruptures)
Cardiogenic shock (inadequate circulation of blood)
Cardiomyopathy (weakening of the heart muscle)

What are the common drug interactions of Mucomyst and Loraz, by age (0-1 to 60+)? *:

0-1:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)

2-9:

n/a

10-19:

Heart rate decreased
Body temperature decreased
Constipation
Dyspepsia (indigestion)
Hypoxia (low oxygen in tissues)
Infrequent bowel movements
Lethargy (tiredness)
Oliguria (not enough urine)
Oxygen saturation decreased
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

20-29:

n/a

30-39:

n/a

40-49:

Sepsis (a severe blood infection that can lead to organ failure and death)
Abdominal wound dehiscence (abdominal wound ruptures)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block second degree (heart block second degree)
Cardiac failure congestive
Cardiogenic shock (inadequate circulation of blood)
Cardiomyopathy (weakening of the heart muscle)
Chest pain
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

50-59:

Erythema (redness of the skin)
Eye disorder
Fall
Fear
Gait disturbance
Groin abscess (pus in groin)
Headache (pain in head)
Injury
Joint swelling
Nervous system disorder (a general class of medical conditions affecting the nervous system)

60+:

Pneumonia
Pyrexia (fever)
Staphylococcal infection (an infection with staphylococcus bacteria)
Vomiting
Cellulitis (infection under the skin)
Constipation
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Febrile neutropenia (fever with reduced white blood cells)
Hyperbilirubinaemia (excess of bilirubin in the blood)

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 14.29%
Constipation: 7 people, 14.29%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 12.24%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 12.24%
Bone Marrow Conditioning Regimen: 6 people, 12.24%
Pain: 5 people, 10.20%
Nausea (feeling of having an urge to vomit): 5 people, 10.20%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 10.20%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 8.16%
Pancreatic Carcinoma (pancreatic cancer): 4 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Mucomyst and Loraz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously